P. Kwasny

One course of adjuvant PEB chemotherapy versus retroperitoneal lymph node dissection in patients with stage I non-seminomatous germ-cell tumors (NSGCT): Results of the German Prospective Multicenter Trial (Association of Urological Oncology [AUO]/German Testicular Cancer Study Group [GTCSG] Trial 01

R. Fimmers, P. Albers, M. Hartmann, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ergebnisse der randomisierten Phase-III-Studie der „German Testicular Cancer Study Group“

R. Fimmers, P. Albers, L. Weissbach, 2009, Der Urologe.

Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection - A 13-year follow-up analysis of a phase III trial cohort.

R. Fimmers, P. Albers, A. Hiester, 2021, European journal of cancer.

[Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I].

R. Fimmers, P. Albers, L. Weissbach, 2009, Der Urologe. Ausg. A.